Literature DB >> 6211245

Soluble inhibitory factor (SIF) in normal human serum.

R L Wolf, J Andreoni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211245     DOI: 10.1016/0008-8749(82)90222-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

Review 1.  Suppressor lipid-protein complexes of normal human serum.

Authors:  R L Wolf
Journal:  Surv Immunol Res       Date:  1982

2.  Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation.

Authors:  L Biancone; M Boirivant; S Fais; G L Ricci; R Paganelli; F Pallone
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 3.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

4.  Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders.

Authors:  J Y Djeu; T Kasahara; J E Balow; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

5.  The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2).

Authors:  M Allegretta; M B Atkins; R A Dempsey; E C Bradley; M W Konrad; A Childs; S N Wolfe; J W Mier
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

6.  Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus.

Authors:  E J Kucharz; S Sierakowski; J S Goodwin
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.